These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28747098)

  • 1. Effect of Mesenchymal Stromal Cells on T Cells in a Septic Context: Immunosuppression or Immunostimulation?
    Le Burel S; Thepenier C; Boutin L; Lataillade JJ; Peltzer J
    Stem Cells Dev; 2017 Oct; 26(20):1477-1489. PubMed ID: 28747098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells.
    Kronsteiner B; Wolbank S; Peterbauer A; Hackl C; Redl H; van Griensven M; Gabriel C
    Stem Cells Dev; 2011 Dec; 20(12):2115-26. PubMed ID: 21381973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
    Zimmermann JA; Hettiaratchi MH; McDevitt TC
    Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing.
    Chinnadurai R; Copland IB; Garcia MA; Petersen CT; Lewis CN; Waller EK; Kirk AD; Galipeau J
    Stem Cells; 2016 Sep; 34(9):2429-42. PubMed ID: 27299362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human umbilical cord-derived mesenchymal stem cells suppress proliferation of PHA-activated lymphocytes in vitro by inducing CD4(+)CD25(high)CD45RA(+) regulatory T cell production and modulating cytokine secretion.
    Yang H; Sun J; Li Y; Duan WM; Bi J; Qu T
    Cell Immunol; 2016 Apr; 302():26-31. PubMed ID: 26774852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DSP30 enhances the immunosuppressive properties of mesenchymal stromal cells and protects their suppressive potential from lipopolysaccharide effects: A potential role of adenosine.
    Sangiorgi B; De Freitas HT; Schiavinato JL; Leão V; Haddad R; Orellana MD; Faça VM; Ferreira GA; Covas DT; Zago MA; Panepucci RA
    Cytotherapy; 2016 Jul; 18(7):846-59. PubMed ID: 27260206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
    Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
    Front Immunol; 2020; 11():54. PubMed ID: 32117234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
    Herzig MC; Delavan CP; Jensen KJ; Cantu C; Montgomery RK; Christy BA; Cap AP; Bynum JA
    J Immunol Methods; 2021 Jan; 488():112915. PubMed ID: 33212091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
    Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
    Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.
    Ciccocioppo R; Cangemi GC; Kruzliak P; Gallia A; Betti E; Badulli C; Martinetti M; Cervio M; Pecci A; Bozzi V; Dionigi P; Visai L; Gurrado A; Alvisi C; Picone C; Monti M; Bernardo ME; Gobbi P; Corazza GR
    Stem Cell Res Ther; 2015 Jul; 6(1):137. PubMed ID: 26206376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible indoleamine 2,3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cells.
    Guan Q; Li Y; Shpiruk T; Bhagwat S; Wall DA
    Cytotherapy; 2018 May; 20(5):639-649. PubMed ID: 29548707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro.
    Conforti A; Scarsella M; Starc N; Giorda E; Biagini S; Proia A; Carsetti R; Locatelli F; Bernardo ME
    Stem Cells Dev; 2014 Nov; 23(21):2591-9. PubMed ID: 24937591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1.
    Sheng H; Wang Y; Jin Y; Zhang Q; Zhang Y; Wang L; Shen B; Yin S; Liu W; Cui L; Li N
    Cell Res; 2008 Aug; 18(8):846-57. PubMed ID: 18607390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Immunomodulatory Effect of Triptolide on Mesenchymal Stromal Cells.
    He H; Takahashi A; Mukai T; Hori A; Narita M; Tojo A; Yang T; Nagamura-Inoue T
    Front Immunol; 2021; 12():686356. PubMed ID: 34484183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes.
    Zanone MM; Favaro E; Miceli I; Grassi G; Camussi E; Caorsi C; Amoroso A; Giovarelli M; Perin PC; Camussi G
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3788-97. PubMed ID: 20466784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions.
    Najar M; Raicevic G; Id Boufker H; Stamatopoulos B; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
    Exp Hematol; 2010 Oct; 38(10):922-32. PubMed ID: 20570633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
    Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
    Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor.
    Najar M; Raicevic G; Boufker HI; Fayyad-Kazan H; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
    Tissue Eng Part A; 2010 Nov; 16(11):3537-46. PubMed ID: 20597819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological profiling using machine learning reveals emergent subpopulations of interferon-γ-stimulated mesenchymal stromal cells that predict immunosuppression.
    Marklein RA; Klinker MW; Drake KA; Polikowsky HG; Lessey-Morillon EC; Bauer SR
    Cytotherapy; 2019 Jan; 21(1):17-31. PubMed ID: 30503100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.